Moreover, Tong et al acclaimed NGAL was down-regulated significantly after EGF treatment along with a concomitant reduction of E-cadherin in pancreatic ductal adenocarcinoma [44]. This evidence concerns the gene LCN2 and pancreatic ductal adenocarcinoma.